New Ablation Balloon Catheter Treatment for Barrett's Esophagus Launched
By MedImaging International staff writers Posted on 09 May 2016 |
Image: The Barrx 360 Express Radio-Frequency Ablation (RFA) catheter can be used to treat Barrett\'s esophagus (Photo courtesy of Medtronic).
A leading biomedical healthcare provider has launched a new express Radio-Frequency Ablation (RFA) catheter that can reduce the risk of low-grade dysplasia by treating a precancerous condition called Barrett's esophagus.
The incidence of esophageal cancer is increasing faster than prostate cancer, breast cancer, and melanoma in the US. Barrett's esophagus, a result of chronic injury from Gastro-Esophageal Reflux Disease (GERD), affects more than 12 million adults in America today.
The Medtronic (Dublin, Ireland) Barrx 360 Express catheter is a self-adjusting circumferential RFA catheter that enables gastroenterologists and surgeons to provide targeted precision therapy for treating Barrett’s esophagus. The RFA treatment removes diseased tissue with minimal damage to healthy tissue in the esophagus. The RFA therapy can reduce the risk of low-grade dysplasia progressing to cancer of the esophagus, by around 90%.
The new design of the Barrx 360 Express catheter can reduce procedure times by 20% by simplifying workflow steps and increasing the efficiency of Barrett's tissue ablation.
The Barrx 360 Express RFA balloon catheter is being launched first in the US, but is also expected to be on sale in New Zealand, Australia, and the EU in 2016.
Vafa Jamali, president Early Technologies, Medtronic Minimally Invasive Therapies, said, "In reducing the progression of dysplastic Barrett's esophagus to esophageal cancer, the launch of the Barrx 360 Express RFA balloon catheter underscores our commitment to patients. We believe patients and physicians will benefit from the easier-to-use technology of the Barrx 360 Express catheter, which provides a more precise delivery of RF energy to the targeted area."
Related Links:
Medtronic
The incidence of esophageal cancer is increasing faster than prostate cancer, breast cancer, and melanoma in the US. Barrett's esophagus, a result of chronic injury from Gastro-Esophageal Reflux Disease (GERD), affects more than 12 million adults in America today.
The Medtronic (Dublin, Ireland) Barrx 360 Express catheter is a self-adjusting circumferential RFA catheter that enables gastroenterologists and surgeons to provide targeted precision therapy for treating Barrett’s esophagus. The RFA treatment removes diseased tissue with minimal damage to healthy tissue in the esophagus. The RFA therapy can reduce the risk of low-grade dysplasia progressing to cancer of the esophagus, by around 90%.
The new design of the Barrx 360 Express catheter can reduce procedure times by 20% by simplifying workflow steps and increasing the efficiency of Barrett's tissue ablation.
The Barrx 360 Express RFA balloon catheter is being launched first in the US, but is also expected to be on sale in New Zealand, Australia, and the EU in 2016.
Vafa Jamali, president Early Technologies, Medtronic Minimally Invasive Therapies, said, "In reducing the progression of dysplastic Barrett's esophagus to esophageal cancer, the launch of the Barrx 360 Express RFA balloon catheter underscores our commitment to patients. We believe patients and physicians will benefit from the easier-to-use technology of the Barrx 360 Express catheter, which provides a more precise delivery of RF energy to the targeted area."
Related Links:
Medtronic
Latest General/Advanced Imaging News
- Bone Density Test Uses Existing CT Images to Predict Fractures
- AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging